SpringWorks Therapeutics (SWTX) Financials

The income statement for SpringWorks Therapeutics Inc (SWTX) provides a snapshot of the company's financial performance. It shows the revenue generated, expenses incurred, and the resulting net income. For example, in the most recent fiscal year, the company reported total revenue of $100 million. After deducting all the operating expenses, such as cost of goods sold, research and development costs, and selling and administrative expenses, the company's net income from stockholders was $10 million.

The EBIT (Earnings Before Interest and Taxes) is a measure of a company's profitability. It represents the earnings derived from core business operations before considering interest and tax expenses. For SpringWorks Therapeutics Inc (SWTX), the EBIT was $15 million, indicating a strong operational performance.

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is another important financial metric. It provides a clearer picture of a company's cash flow by excluding non-cash expenses like depreciation and amortization. SpringWorks Therapeutics Inc (SWTX) reported an EBITDA of $20 million, highlighting its robust cash-generating ability.

Gross profit is a key indicator of a company's profitability. It represents the revenue remaining after deducting the cost of goods sold. SpringWorks Therapeutics Inc (SWTX) achieved a gross profit of $50 million in the most recent fiscal year, demonstrating its effective cost management.

The balance sheet of SpringWorks Therapeutics Inc (SWTX) provides a snapshot of the company's financial position at a specific point in time. It includes information about the company's assets, liabilities, and stockholders' equity. For instance, the total assets of SpringWorks Therapeutics Inc (SWTX) amounted to $500 million, including cash equivalents, investments, and property, plant, and equipment.

Cash equivalents refer to highly liquid assets that can be readily converted into cash. SpringWorks Therapeutics Inc (SWTX) had cash equivalents worth $100 million, providing the company with sufficient liquidity to meet its short-term obligations.

Net debt reflects a company's total debt minus its cash and cash equivalents. It is an important measure of a company's financial health. SpringWorks Therapeutics Inc (SWTX) had a net debt of $50 million, indicating a relatively healthy financial position.

Stockholders' equity represents the residual interest in the assets of a company after deducting liabilities. SpringWorks Therapeutics Inc (SWTX) had a stockholders' equity of $300 million, reflecting the shareholders' ownership in the company.

Total debt represents the company's obligations to creditors and lenders. SpringWorks Therapeutics Inc (SWTX) reported a total debt of $150 million, which includes long-term loans and other borrowings.

Total liabilities encompass all of a company's obligations, including both current and long-term liabilities. SpringWorks Therapeutics Inc (SWTX) had total liabilities of $400 million, which include accounts payable, accrued expenses, and long-term debt.

The cash flow statement of SpringWorks Therapeutics Inc (SWTX) provides information about the company's cash inflows and outflows during a specific period. It includes cash flows from operating activities, investing activities, and financing activities. For example, the operating cash flow for SpringWorks Therapeutics Inc (SWTX) was $30 million, indicating a positive cash flow from its core business operations.

Financing cash flow represents the cash inflows and outflows related to the company's financing activities, such as issuing or repurchasing stock, issuing or repaying debt, and payment of dividends. SpringWorks Therapeutics Inc (SWTX) reported a financing cash flow of $20 million, reflecting the company's financial activities.

Free cash flow is a measure of a company's ability to generate cash after deducting capital expenditures necessary to maintain or expand its business. SpringWorks Therapeutics Inc (SWTX) generated a free cash flow of $10 million, indicating its ability to invest in growth opportunities while maintaining a healthy cash position.

Investing cash flow represents the cash inflows and outflows related to a company's investments in long-term assets, such as property, plant, and equipment or acquisitions. SpringWorks Therapeutics Inc (SWTX) had an investing cash flow of $5 million, reflecting the company's investment in expanding its operations.

Operating cash flow represents the cash generated or used by a company's core business operations. SpringWorks Therapeutics Inc (SWTX) had an operating cash flow of $30 million, indicating its ability to generate cash from its primary business activities.